Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
PPP1R2
Introduction
Protein phosphatase inhibitor 2 is an enzyme that in humans is encoded by the PPP1R2 gene.[1][2][3]
References
References
- ↑ Permana PA, Mott DM (May 1997). “Genetic analysis of human type 1 protein phosphatase inhibitor 2 in insulin-resistant Pima Indians”. Genomics. 41 (1): 110–4. doi:10.1006/geno.1997.4649. PMID 9126490.
- ↑ Helps NR, Street AJ, Elledge SJ, Cohen PT (Apr 1994). “Cloning of the complete coding region for human protein phosphatase inhibitor 2 using the two hybrid system and expression of inhibitor 2 in E. coli”. FEBS Lett. 340 (1–2): 93–8. doi:10.1016/0014-5793(94)80179-7. PMID 8119416.
- ↑ “Entrez Gene: PPP1R2 protein phosphatase 1, regulatory (inhibitor) subunit 2”.
- ↑ Wang, Hong; Brautigan David L (Dec 2002). “A novel transmembrane Ser/Thr kinase complexes with protein phosphatase-1 and inhibitor-2”. J. Biol. Chem. United States. 277 (51): 49605–12. doi:10.1074/jbc.M209335200. ISSN 0021-9258. PMID 12393858.
- ↑ Terry-Lorenzo, Ryan T; Elliot Elizabeth; Weiser Douglas C; Prickett Todd D; Brautigan David L; Shenolikar Shirish (Nov 2002). “Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton”. J. Biol. Chem. United States. 277 (48): 46535–43. doi:10.1074/jbc.M206960200. ISSN 0021-9258. PMID 12270929.
Further reading
Further reading
- Sanséau P, Jackson A, Alderton RP, et al. (1994). “Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences”. Mamm. Genome. 5 (8): 490–6. doi:10.1007/BF00369318. PMID 7949733.
- Park IK, Roach P, Bondor J, et al. (1994). “Molecular mechanism of the synergistic phosphorylation of phosphatase inhibitor-2. Cloning, expression, and site-directed mutagenesis of inhibitor-2”. J. Biol. Chem. 269 (2): 944–54. PMID 8288648.
- Kakinoki Y, Somers J, Brautigan DL (1998). “Multisite phosphorylation and the nuclear localization of phosphatase inhibitor 2-green fluorescent protein fusion protein during S phase of the cell growth cycle”. J. Biol. Chem. 272 (51): 32308–14. doi:10.1074/jbc.272.51.32308. PMID 9405437.
- Yang J, Hurley TD, DePaoli-Roach AA (2000). “Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase. Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif”. J. Biol. Chem. 275 (30): 22635–44. doi:10.1074/jbc.M003082200. PMID 10807923.
- Agarwal-Mawal A, Paudel HK (2001). “Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2”. J. Biol. Chem. 276 (26): 23712–8. doi:10.1074/jbc.M010002200. PMID 11320080.
- Eto M, Elliott E, Prickett TD, Brautigan DL (2003). “Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation”. J. Biol. Chem. 277 (46): 44013–20. doi:10.1074/jbc.M208035200. PMID 12221103.
- Terry-Lorenzo RT, Elliot E, Weiser DC, et al. (2003). “Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton”. J. Biol. Chem. 277 (48): 46535–43. doi:10.1074/jbc.M206960200. PMID 12270929.
- Wang H, Brautigan DL (2003). “A novel transmembrane Ser/Thr kinase complexes with protein phosphatase-1 and inhibitor-2”. J. Biol. Chem. 277 (51): 49605–12. doi:10.1074/jbc.M209335200. PMID 12393858.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Gevaert K, Goethals M, Martens L, et al. (2004). “Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides”. Nat. Biotechnol. 21 (5): 566–9. doi:10.1038/nbt810. PMID 12665801.
- Leach C, Shenolikar S, Brautigan DL (2003). “Phosphorylation of phosphatase inhibitor-2 at centrosomes during mitosis”. J. Biol. Chem. 278 (28): 26015–20. doi:10.1074/jbc.M300782200. PMID 12697755.
- Sakashita G, Shima H, Komatsu M, et al. (2004). “Regulation of type 1 protein phosphatase/inhibitor-2 complex by glycogen synthase kinase-3beta in intact cells”. J. Biochem. 133 (2): 165–71. doi:10.1093/jb/mvg020. PMID 12761178.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. Bibcode:2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514.
- Yamada M, Ikeda Y, Yano M, et al. (2006). “Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy”. FASEB J. 20 (8): 1197–9. doi:10.1096/fj.05-5299fje. PMID 16627625.
- King TD, Gandy JC, Bijur GN (2007). “The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels”. Exp. Cell Res. 312 (18): 3693–700. doi:10.1016/j.yexcr.2006.08.010. PMC 1885546. PMID 16987514.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.